The Radiolabeling Services Market Size is predicted to exhibit an 18.6% CAGR during the forecast period for 2024-2031.
The market for radiolabeling services plays a critical role in fulfilling the needs of scientific research into pharmaceuticals, medical diagnostics, and environment studies. Radiolabeling is a process where radioactive isotopes are attached to molecules, allowing these compounds to be tracked in biological systems or chemical reactions. This is of vital importance in studies on drug metabolism, diagnosis through imaging techniques like PET and MRI, and environmental studies monitoring pollutants. The data regarding the efficacy and safety of drugs, as well as their ecological dynamics, is revealed through radiolabeled compounds.
Rapid, innovative drug development is one major growth driver for the market of radiolabeling services. Pharmaceutical companies rely more on radiolabeling to hasten research so that they may accurately track drug behavior. Technological advancements in the process of radiolabeling further boost efficiency and accuracy, hence hastening therapeutic progress, as well as accurate ecological research. Radiolabeling supports an advancement of health outcomes as well as an improvement of environmental knowledge.
The Radiolabeling Services market is segmented by product type application. By product type the market is segmented into C-14, H-3, I-125, Others. By application market is categorized into pharmacokinetics and pharmacodynamics, medical, others.
Tritium (H-3) is a growth engine for the radiolabeling services market as it is the most efficient and cost-effective method of drug development. The utilization of tritium is extremely widespread in medicinal chemistry for compound labeling, thus enabling researchers to monitor a drug's ADME in the early phases of discovery about the effectiveness and safety levels of drug matters. The current methods of tritium labeling have been enhanced to produce easier, one-step labeling that does not alter the properties biological, hence easier to use for researchers. Additionally, Tritium labeling is almost 100 times cheaper compared to other alternative methods such as Carbon-14(C-14), and this makes it possible to carry out voluminous pharmaceutical research at very minimal costs.
The PK and PD segment within radiolabeling services is growing at a fast pace, mainly because critical information regarding the behavior of the drug in the body needs to be gathered for both the development of the drug and to be put in regulatory compliance. Strict regulatory requirements demand comprehensive PK/PD studies to measure the absorption, distribution, metabolization, and excretion of drugs and their effects on the body. Advances in personalized medicine and targeted therapies necessitate advanced PK/PD analysis to drug design for right and optimal effect with a minimum side effect. Biopharmaceutical research investment is continually on the rise and also has helped create the idea of preparing radiolabeled compounds for more detailed studies of drug interactions and metabolic pathways in the human body.
North America dominates the market share for radiolabeling services because of a strong pharmaceutical industry, research infrastructure, regulatory compliance, and continuous technology advancements. The pharmaceutical sector in the United States spends heavily on research, creating an industry-wide need for the radiolabeling services to be done to support detailed pharmacokinetics and pharmacodynamics studies that are required to develop and gain regulatory approval for most drugs.
Advanced research institutions throughout the region conduct radiolabeling in the areas of drug discovery, diagnostics, and environmental research, which therefore encourages significant penetration. Additionally, rigorous regulatory demands require testing of drugs in all possible ways, which translates to a direct increase in reliance on radiolabeling. More recent technological breakthroughs, bolstered by high investment levels, result in making techniques and processes more time and money efficient, therefore pushing pharmaceutical and research industries toward services they offer.
|
Report Attribute |
Specifications |
|
Growth Rate CAGR |
CAGR of 18.6% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product Type, Application and By Region |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; Southeast Asia |
|
Competitive Landscape |
Charles River, Eurofins Scientific, PerkinElmer, Sekisui Medical, Eckert & Ziegler, Labcorp, XenoTech (BioIVT), Quotient Sciences, Gifford Bioscience, ITM Radiopharma, Almac Group, Accelera, Novandi Chemistry, AptoChem, HMR, AM Chemicals, PolyPeptide Group, NovoPro Bioscience, Institute of Isotopes, Nuvisan, Revvity, Necsa, Fluorizon, Edinburgh Pharmaceutical Processes, Pharmaron, Medicilon, JOINN Laboratories, Frontage, Abace Biotechnology, Beijing Atom High-Tech, Wuxi Beita Pharmatech, Beijing North Institute of Biotechnology |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Radiolabeling Services Market Snapshot
Chapter 4. Global Radiolabeling Services Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031
4.8. Global Radiolabeling Services Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on Radiolabeling Services Industry Trends
Chapter 5. Radiolabeling Services Market Segmentation 1: By Product Type, Estimates & Trend Analysis
5.1. Market Share by Product Type, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Product Type:
5.2.1. C-14
5.2.2. H-3
5.2.3. I-125
5.2.4. Others
Chapter 6. Radiolabeling Services Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Applications:
6.2.1. Pharmacokinetics and Pharmacodynamics
6.2.2. Medical
6.2.3. Others
Chapter 7. Radiolabeling Services Market Segmentation 4: Regional Estimates & Trend Analysis
7.1. Global Radiolabeling Services Market, Regional Snapshot 2023 & 2031
7.2. North America
7.2.1. North America Radiolabeling Services Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
7.2.1.1. US
7.2.1.2. Canada
7.2.2. North America Radiolabeling Services Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
7.2.3. North America Radiolabeling Services Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
7.3. Europe
7.3.1. Europe Radiolabeling Services Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
7.3.1.1. Germany
7.3.1.2. U.K.
7.3.1.3. France
7.3.1.4. Italy
7.3.1.5. Spain
7.3.1.6. Rest of Europe
7.3.2. Europe Radiolabeling Services Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
7.3.3. Europe Radiolabeling Services Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
7.4. Asia Pacific
7.4.1. Asia Pacific Radiolabeling Services Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
7.4.1.1. India
7.4.1.2. China
7.4.1.3. Japan
7.4.1.4. Australia
7.4.1.5. South Korea
7.4.1.6. Hong Kong
7.4.1.7. Southeast Asia
7.4.1.8. Rest of Asia Pacific
7.4.2. Asia Pacific Radiolabeling Services Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
7.4.3. Asia Pacific Radiolabeling Services Market Revenue (US$ Million) Estimates and Forecasts By Application, 2024-2031
7.5. Latin America
7.5.1. Latin America Radiolabeling Services Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
7.5.1.1. Brazil
7.5.1.2. Mexico
7.5.1.3. Rest of Latin America
7.5.2. Latin America Radiolabeling Services Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
7.5.3. Latin America Radiolabeling Services Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
7.6. Middle East & Africa
7.6.1. Middle East & Africa Radiolabeling Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.6.1.1. GCC Countries
7.6.1.2. Israel
7.6.1.3. South Africa
7.6.1.4. Rest of Middle East and Africa
7.6.2. Middle East & Africa Radiolabeling Services Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
7.6.3. Middle East & Africa Radiolabeling Services Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Charles River
8.2.1.1. Business Overview
8.2.1.2. Key Product/Service Offerings
8.2.1.3. Financial Performance
8.2.1.4. Geographical Presence
8.2.1.5. Recent Developments with Business Strategy
8.2.2. Eurofins Scientific
8.2.3. PerkinElmer
8.2.4. Sekisui Medical
8.2.5. Eckert & Ziegler
8.2.6. Labcorp
8.2.7. XenoTech (BioIVT)
8.2.8. Quotient Sciences
8.2.9. Gifford Bioscience
8.2.10. ITM Radiopharma
8.2.11. Almac Group
8.2.12. Accelera
8.2.13. Novandi Chemistry
8.2.14. AptoChem
8.2.15. HMR
8.2.16. AM Chemicals
8.2.17. PolyPeptide Group
8.2.18. NovoPro Bioscience
8.2.19. Institute of Isotopes
8.2.20. Nuvisan
8.2.21. Revvity
8.2.22. Necsa
8.2.23. Fluorizon
8.2.24. Edinburgh Pharmaceutical Processes
8.2.25. Pharmaron
8.2.26. Medicilon
8.2.27. JOINN Laboratories
8.2.28. Frontage
8.2.29. Abace Biotechnology
8.2.30. Beijing Atom High-Tech
8.2.31. Wuxi Beita Pharmatech
8.2.32. Beijing North Institute of Biotechnology
8.2.33. Other Prominent Players
Radiolabeling Services Market by Product Type -
Radiolabeling Services Market by Application -
Radiolabeling Services Market by Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
